Biodesix Inc   (BDSX)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $1.5800 $0.11 7.483%
Day's High: $1.58 Week Perf: 6.76 %
Day's Low: $ 1.46 30 Day Perf: -21.39 %
Volume (M): 52 52 Wk High: $ 2.27
Volume (M$): $ 82 52 Wk Avg: $1.57
Open: $1.47 52 Wk Low: $1.03

 Market Capitalization (Millions $) 126
 Shares Outstanding (Millions) 80
 Employees -
 Revenues (TTM) (Millions $) 44
 Net Income (TTM) (Millions $) -63
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 22

Biodesix Inc
Biodesix Inc is a molecular diagnostics company that specializes in the development and commercialization of diagnostic tests for various diseases, including cancer. The company focuses on personalized medicine, aiming to provide physicians with actionable information that can help in making treatment decisions for their patients. Biodesix offers a range of tests that utilize advanced technology platforms to analyze genetic and proteomic biomarkers with the goal of improving patient outcomes. Their innovative diagnostic tests are designed to enable early disease detection, treatment monitoring, and prediction of disease progression.

   Company Address: 2970 Wilderness Place, Boulder 80301 CO
   Company Phone Number: 417-0500   Stock Exchange / Ticker: NASDAQ BDSX
   BDSX is expected to report next financial results on March 05, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Biodesix Inc

Biodesix Inc Surges Towards Profitability With Remarkable Q3 2023 Performance

Biodesix Inc, a leading provider of diagnostic solutions for lung diseases, has shown impressive improvement in its financial performance for the third quarter of 2023. The company reported a decrease in loss per share, with a significant improvement from $-0.34 per share in the same quarter a year ago to $-0.14 per share. Additionally, the company's earnings per share (EPS) improved from $-0.17 per share in the preceding quarter. These positive results indicate that Biodesix Inc is moving in the right direction and making strides towards profitability.
One of the key factors contributing to Biodesix Inc's positive performance is its revenue growth. The company witnessed a rapid increase in revenue of 21.464% to $13.49 million, compared to $11.11 million in the same quarter a year ago. Sequentially, the revenue also advanced by 13.637% from $11.87 million in the previous quarter. These impressive growth figures highlight the company's ability to attract more customers and generate higher sales.

Biodesix Inc

BDSX Gaining Financial Stability; Deficit Significantly Reduces in Q2 2023

During the past 5 trading days, Biodesix Inc's stock experienced a significant drop of -10.83%. This decline contributes to the year-to-date performance, which now stands at -47.8%. Additionally, the stock currently trades 12% above its 52-week low. These statistics may be concerning for investors and warrant further analysis of the company's financial performance and industry outlook.
Looking at the financial results for the April to June 2023 time-frame, Biodesix Inc showed signs of improvement compared to the previous year. The loss per share decreased from $-0.40 to $-0.17, indicating progress in managing expenses. Moreover, the income per share also improved, moving from $-0.24 to an undisclosed positive value, which is a positive development for the company.

Biodesix Inc

1. Biodesix Inc Achieves Remarkable Turnaround, Slashing Losses and Surpassing Financial Goals

Biodesix Inc recently released its financial report for the most recent fiscal period, and the results were positive. The company was able to decrease its loss per share from $-0.50 to $-0.24, indicating an improvement in their financial performance. In addition, their income per share increased from $-0.29 to an unspecified amount, suggesting that the company is on track in meeting its financial goals.
One significant factor in Biodesix Inc's performance is their increase in revenue. The company reported a revenue increase of 38.302% to $9.06 million, compared to $6.55 million from the same period last year. However, this is a sequential decrease from $9.61 million, indicating that there may be some fluctuations in revenue from period to period. It is essential to recognize that revenue is a crucial factor in a company's overall financial performance, and Biodesix Inc's revenue growth is a positive indication of their success.


Biodesix Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com